# Christopher D. Byrne

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/christopher-d-byrne/

## Facts

| Field | Value |
| --- | --- |
| Citations | 51,071 |
| Field | Liver Disease Diagnosis and Treatment |
| h-index | 109 |
| i10-index | 449 |
| Last Known Institution | Southampton General Hospital |
| OpenAlex ID | https://openalex.org/A5090673306 |
| ORCID iD | 0000-0001-6322-7753 |
| Works | 823 |

## Researcher papers

Showing 12 of 15.

- [NAFLD: A multisystem disease](https://scholariq.org/papers/nafld-a-multisystem-disease/)
- [A multisociety Delphi consensus statement on new fatty liver disease nomenclature](https://scholariq.org/papers/a-multisociety-delphi-consensus-statement-on-new-fatty-liver-disease/)
- [A multisociety Delphi consensus statement on new fatty liver disease nomenclature](https://scholariq.org/papers/a-multisociety-delphi-consensus-statement-on-new-fatty-liver-disease-3/)
- [Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis](https://scholariq.org/papers/non-alcoholic-fatty-liver-disease-and-risk-of-incident-cardiovascular-disease-a/)
- [The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments](https://scholariq.org/papers/the-complex-link-between-nafld-and-type-2-diabetes-mellitus-mechanisms-and/)
- [MASLD: a systemic metabolic disorder with cardiovascular and malignant complications](https://scholariq.org/papers/masld-a-systemic-metabolic-disorder-with-cardiovascular-and-malignant/)
- [A multisociety Delphi consensus statement on new fatty liver disease nomenclature](https://scholariq.org/papers/a-multisociety-delphi-consensus-statement-on-new-fatty-liver-disease-2/)
- [NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications](https://scholariq.org/papers/nafld-and-increased-risk-of-cardiovascular-disease-clinical-associations/)
- [Advancing the global public health agenda for NAFLD: a consensus statement](https://scholariq.org/papers/advancing-the-global-public-health-agenda-for-nafld-a-consensus-statement/)
- [Current status and future trends of the global burden of MASLD](https://scholariq.org/papers/current-status-and-future-trends-of-the-global-burden-of-masld/)
- [Global burden of metabolic diseases, 1990–2021](https://scholariq.org/papers/global-burden-of-metabolic-diseases-1990-2021/)
- [Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021](https://scholariq.org/papers/burden-of-disease-attributable-to-high-body-mass-index-an-analysis-of-data-from/)

## Researcher topics

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Diet, Metabolism, and Disease](https://scholariq.org/topics/diet-metabolism-and-disease/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [Alcohol Consumption and Health Effects](https://scholariq.org/topics/alcohol-consumption-and-health-effects/)

## Researcher university

- [Southampton General Hospital](https://scholariq.org/institutions/southampton-general-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.